Health Information Management

Tip: CMS issues revision of October I/OCE update

APCs Insider, December 4, 2015

Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

CMS issued a revision of the October 2015 I/OCE update that included changes for HCPCS code Q5101 (injection, filgrastim [G-CSF], biosimilar, 1 microgram). CMS originally approved the code for use July 1, 2015, and assigned it a status indicator E (services not paid, non-allowed item or service).
 
CMS changed the status indicator for code Q5101 to K (non-pass-through drugs and biologicals, and blood and blood products) and assigned it to new APC 1822.

 

This tip is adapted from “NCCI logic could lead to no payment for claims including comprehensive APCs” in the December issue of Briefings on APCs.



Want to receive articles like this one in your inbox? Subscribe to APCs Insider!

    Briefings on APCs
  • Briefings on APCs

    Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...

  • HIM Briefings

    Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...

  • Briefings on Coding Compliance Strategies

    Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...

  • Briefings on HIPAA

    How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...

  • APCs Insider

    This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...

Most Popular